 BEVERLY, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG LexaGene or the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it successfully utilized its MiQLabTM System MiQLab to detect the presence of multiple strains of pathogenic bacteria in polymicrobial samples that vary in their antimicrobial resistance AMR. These samples were missed by traditional Culture and Sensitivity Testing CST, and the time-to-results were orders-of-magnitude faster for the MiQLab. 